Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Progress and challenges in implementing the research on ESKAPE pathogens.

Rice LB.

Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S7-10. doi: 10.1086/655995.

PMID:
20929376
2.

Clinical relevance of the ESKAPE pathogens.

Pendleton JN, Gorman SP, Gilmore BF.

Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308. doi: 10.1586/eri.13.12. Review.

PMID:
23458769
3.

Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.

Flynn PB, Higginbotham S, Alshraiedeh NH, Gorman SP, Graham WG, Gilmore BF.

Int J Antimicrob Agents. 2015 Jul;46(1):101-7. doi: 10.1016/j.ijantimicag.2015.02.026. Epub 2015 Apr 20.

PMID:
25963338
4.

Overview perspective of bacterial resistance.

Furtado GH, Nicolau DP.

Expert Opin Ther Pat. 2010 Oct;20(10):1273-6. doi: 10.1517/13543776.2010.507193.

PMID:
20687782
5.

ESKAPEing the labyrinth of antibacterial discovery.

Tommasi R, Brown DG, Walkup GK, Manchester JI, Miller AA.

Nat Rev Drug Discov. 2015 Aug;14(8):529-42. doi: 10.1038/nrd4572. Epub 2015 Jul 3. Review. Erratum in: Nat Rev Drug Discov. 2015 Sep;14(9):662.

PMID:
26139286
6.

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.

Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8.

PMID:
16105565
7.

One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico.

Llaca-Díaz JM, Mendoza-Olazarán S, Camacho-Ortiz A, Flores S, Garza-González E.

Chemotherapy. 2012;58(6):475-81. doi: 10.1159/000346352. Epub 2013 Mar 21.

8.
10.

Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.

Behroozian S, Svensson SL, Davies J.

MBio. 2016 Jan 26;7(1):e01842-15. doi: 10.1128/mBio.01842-15.

11.

Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.

Du H, Puri S, McCall A, Norris HL, Russo T, Edgerton M.

Front Cell Infect Microbiol. 2017 Feb 15;7:41. doi: 10.3389/fcimb.2017.00041. eCollection 2017.

12.

Pathogens resistant to antibacterial agents.

Chen LF, Chopra T, Kaye KS.

Infect Dis Clin North Am. 2009 Dec;23(4):817-45, vii. doi: 10.1016/j.idc.2009.06.002. Review.

PMID:
19909886
13.

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.

Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):187-93.

PMID:
16105563
15.

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.

Santajit S, Indrawattana N.

Biomed Res Int. 2016;2016:2475067. doi: 10.1155/2016/2475067. Epub 2016 May 5. Review.

16.

In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.

Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.

J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.

PMID:
11605808
17.

In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.

Kanj SS, Whitelaw A, Dowzicky MJ.

Int J Antimicrob Agents. 2014 Feb;43(2):170-8. doi: 10.1016/j.ijantimicag.2013.10.011. Epub 2013 Nov 15.

PMID:
24315313
18.

Resistant gram-negative bacilli: A neglected healthcare crisis?

Lautenbach E, Polk RE.

Am J Health Syst Pharm. 2007 Dec 1;64(23 Suppl 14):S3-21; quiz S22-4.

PMID:
18029939
19.

Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.

Adam HJ, DeCorby M, Rennie R, Karlowsky JA, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

Diagn Microbiol Infect Dis. 2011 Mar;69(3):307-13. doi: 10.1016/j.diagmicrobio.2010.10.026.

PMID:
21353958
20.

Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.

Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB.

Pediatr Infect Dis J. 2003 Aug;22(8):686-91.

PMID:
12913767

Supplemental Content

Support Center